ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO was delisted on the 27th of March, 2020.
6 hedge funds and large institutions have $896K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 3 → 6 (+3)
4% less capital invested
Capital invested by funds: $934K → $896K (-$38K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$526K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$18.7K |
| 3 |
Morgan Stanley
New York
|
+$3.43K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
+$147 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$234K |
| 2 |
Jane Street
New York
|
-$46.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $479K | +$526K | +14,286 | New |
|
|
2
Jane Street
New York
| $204K | -$46.6K | -1,264 | -17% |
|
|
VF
3
Virtu Financial
New York
| $180K | -$234K | -6,349 | -54% |
|
|
4
UBS Group
Zurich,
Switzerland
| $17K | +$18.7K | +507 | New |
|
|
CG
5
Cutler Group
San Francisco,
California
| $13K | +$147 | +4 | +1% |
|
|
6
Morgan Stanley
New York
| $3K | +$3.43K | +93 | New |
|
ZBIO Hedge Fund Activity: Q1 2017 in Review
6 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) for Q1 2017, worth a combined $896K — down 4.1% from $934K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ZBIO positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $526K. The largest seller was Virtu Financial, cutting an estimated $234K.
- 6 institutional investors held ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) as of Q1 2017, up from 3 in Q4 2016.
- Funds reported $896K of ProShares UltraPro Short NASDAQ Biotechnology stock for Q1 2017, down 4.1% quarter-over-quarter.
- 3 funds opened new ProShares UltraPro Short NASDAQ Biotechnology positions in Q1 2017 and 0 closed out, a net change of +3 holders.
- The largest ProShares UltraPro Short NASDAQ Biotechnology buyer in Q1 2017 was Susquehanna International Group, an estimated $526K added.
- The largest ProShares UltraPro Short NASDAQ Biotechnology seller in Q1 2017 was Virtu Financial, an estimated $234K sold.
Based on aggregated 13F filings for Q1 2017.